These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 15236997

  • 1. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
    Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    Fertil Steril; 2004 Jul; 82(1):102-7. PubMed ID: 15236997
    [Abstract] [Full Text] [Related]

  • 2. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
    Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzis BC, Tournaye H, Devroey P.
    Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
    [Abstract] [Full Text] [Related]

  • 3. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP, Macklon NS, Fauser BC.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [Abstract] [Full Text] [Related]

  • 4. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 5. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
    Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P.
    Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
    [Abstract] [Full Text] [Related]

  • 6. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

  • 7. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN, Phung HT, Ho MT.
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [Abstract] [Full Text] [Related]

  • 8. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.
    Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5632-7. PubMed ID: 14671145
    [Abstract] [Full Text] [Related]

  • 9. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
    Barmat LI, Chantilis SJ, Hurst BS, Dickey RP.
    Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
    [Abstract] [Full Text] [Related]

  • 10. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
    de Jong D, Macklon NS, Eijkemans MJ, Mannaerts BM, Coelingh Bennink HJ, Fauser BC, Ganirelix Dose-Finding Study Group.
    Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
    [Abstract] [Full Text] [Related]

  • 11. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R.
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [Abstract] [Full Text] [Related]

  • 12. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.
    Boostanfar R, Shapiro B, Levy M, Rosenwaks Z, Witjes H, Stegmann BJ, Elbers J, Gordon K, Mannaerts B, Pursue investigators.
    Fertil Steril; 2015 Jul; 104(1):94-103.e1. PubMed ID: 26003273
    [Abstract] [Full Text] [Related]

  • 13. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
    Gómez-Palomares JL, Acevedo-Martín B, Chávez M, Manzanares M, Ricciarelli E, Hernández ER.
    Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
    [Abstract] [Full Text] [Related]

  • 14. Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With "Unpredictable" Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol.
    Zhang C, Wu F, Wu Z, Sun B, Chen C, Qian W.
    Front Endocrinol (Lausanne); 2021 Mar; 12():739773. PubMed ID: 34707571
    [Abstract] [Full Text] [Related]

  • 15. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study.
    Blockeel C, De Vos M, Verpoest W, Stoop D, Haentjens P, Devroey P.
    Hum Reprod; 2009 Nov; 24(11):2910-6. PubMed ID: 19617207
    [Abstract] [Full Text] [Related]

  • 16. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM.
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [Abstract] [Full Text] [Related]

  • 17. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles.
    Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    Hum Reprod; 2005 Sep; 20(9):2453-6. PubMed ID: 15890735
    [Abstract] [Full Text] [Related]

  • 18. What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?
    Samara N, Reis D, Danielli Miller N, Ghetler Y, Berkovitz A, Miller M, Gonen O, Shulman A, Wiser A.
    Gynecol Endocrinol; 2015 Sep; 31(11):877-9. PubMed ID: 26416777
    [Abstract] [Full Text] [Related]

  • 19. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.
    Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    Fertil Steril; 2003 Apr; 79(4):873-80. PubMed ID: 12749423
    [Abstract] [Full Text] [Related]

  • 20. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.
    Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, Devroey P.
    Fertil Steril; 2002 Nov; 78(5):1025-9. PubMed ID: 12413988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.